Prati
John Krauss
John Krauss
Division of Hematology/Oncology, University of Michigan
Potvrđena adresa e-pošte na med.umich.edu
Naslov
Citirano
Citirano
Godina
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
RC Doebele, A Drilon, L Paz-Ares, S Siena, AT Shaw, AF Farago, ...
The Lancet Oncology 21 (2), 271-282, 2020
13242020
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
DS Hong, MG Fakih, JH Strickler, J Desai, GA Durm, GI Shapiro, ...
New England Journal of Medicine 383 (13), 1207-1217, 2020
12562020
Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy
J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim, JB Yuval, HM Thompson, ...
Journal of clinical oncology 40 (23), 2546, 2022
3592022
Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines
J Wang, S Saffold, X Cao, J Krauss, W Chen
The Journal of Immunology 161 (10), 5516-5524, 1998
3221998
Rituximab extended schedule or re-treatment trial for low–tumor burden follicular lymphoma: Eastern Cooperative Oncology Group protocol E4402
BS Kahl, F Hong, ME Williams, RD Gascoyne, LI Wagner, JC Krauss, ...
Journal of Clinical Oncology 32 (28), 3096, 2014
2232014
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
JH Uhm, KV Ballman, W Wu, C Giannini, JC Krauss, JC Buckner, ...
International Journal of Radiation Oncology* Biology* Physics 80 (2), 347-353, 2011
2072011
Systemic T cell adoptive immunotherapy of malignant gliomas
GE Plautz, GH Barnett, DW Miller, BH Cohen, RA Prayson, JC Krauss, ...
Journal of Neurosurgery 89 (1), 42-51, 1998
1841998
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
MG Fakih, S Kopetz, Y Kuboki, TW Kim, PN Munster, JC Krauss, ...
The Lancet Oncology 23 (1), 115-124, 2022
1692022
Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) tumors: pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
GD Demetri, L Paz-Ares, AF Farago, SV Liu, SP Chawla, D Tosi, ES Kim, ...
Annals of oncology 29, viii713, 2018
158*2018
Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3.
JC Krauss, PooH, W Xue, L Mayo-Bond, RF Todd 3rd, HR Petty
Journal of immunology (Baltimore, Md.: 1950) 153 (4), 1769-1777, 1994
1171994
Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma
DT Eitzman, JC Krauss, T Shen, J Cui
1131996
Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus
HD Humes, JC Krauss, DA Cieslinski, AJ Funke
American Journal of Physiology-Renal Physiology 271 (1), F42-F49, 1996
1101996
Tumor immunology
S Shu, GE Plautz, JC Krauss, AE Chang
Jama 278 (22), 1972-1981, 1997
1071997
Isolation Based on l-Selectin Expression of Immune Effector T Cells Derived from Tumor-draining Lymph Nodes
H Kagamu, JE Touhalisky, GE Plautz, JC Krauss, S Shu
Cancer research 56 (19), 4338-4342, 1996
1001996
Interaction of Fcγ receptor type IIIB with complement receptor type 3 in fibroblast transfectants: evidence from lateral diffusion and resonance energy transfer studies
H Poo, JC Krauss, L Mayo-Bond, RF Todd III, HR Petty
Journal of molecular biology 247 (4), 597-603, 1995
981995
Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor.
MJ Arca, JC Krauss, A Aruga, MJ Cameron, S Shu, AE Chang
Cancer gene therapy 3 (1), 39-47, 1996
941996
Results of Eastern Cooperative Oncology Group Protocol E4402 (RESORT): a randomized phase III study comparing two different rituximab dosing strategies for low tumor burden …
BS Kahl, F Hong, ME Williams, RD Gascoyne, LI Wagner, JC Krauss, ...
Blood 118 (21), LBA-6, 2011
832011
Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study
WC To, BG Wood, JC Krauss, M Strome, RM Esclamado, P Lavertu, ...
Archives of Otolaryngology–Head & Neck Surgery 126 (10), 1225-1231, 2000
822000
Correction of CD18-deficient lymphocytes by retrovirus-mediated gene transfer
JM Wilson, AJ Ping, JC Krauss, L Mayo-Bond, CE Rogers, DC Anderson, ...
Science 248 (4961), 1413-1416, 1990
821990
Phase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours
R Govindan, MG Fakih, TJ Price, GS Falchook, J Desai, JC Kuo, ...
Annals of Oncology 30, v163-v164, 2019
702019
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20